Comparative analysis of serum hs-CRP and IL-1β levels in major depressivedisorder patients and healthy controls in a tertiary care setting in Sikkim

Authors

  • Aiusha Mawlong Department of Biochemistry and Psychiatry, Sikkim Manipal Institute of Medical Sciences, Sikkim Manipal University, Gangtok-737102, Sikkim, India
  • Rinchen Doma Bhutia Department of Biochemistry and Psychiatry, Sikkim Manipal Institute of Medical Sciences, Sikkim Manipal University, Gangtok-737102, Sikkim, India
  • Samrat Singh Bhandari Department of Biochemistry and Psychiatry, Sikkim Manipal Institute of Medical Sciences, Sikkim Manipal University, Gangtok-737102, Sikkim, India
  • Mingma Lhamu Sherpa Department of Biochemistry and Psychiatry, Sikkim Manipal Institute of Medical Sciences, Sikkim Manipal University, Gangtok-737102, Sikkim, India

DOI:

https://doi.org/10.56042/ijbb.v63i8.26002

Keywords:

Biomarkers, Brain-derived neurotrophic factor (BDNF), hs-CRP, IL-1β, Hypothalamic-pituitary-adrenal (HPA), Major depressive disorder (MDD), Neuroinflammation

Abstract

Systemic inflammation is increasingly linked to Major Depressive Disorder (MDD), and its expression may vary across populations. This study evaluates serum high sensitive C-reactive protein (hs-CRP) and Interleukin-1β (IL-1β) levels in MDD patients (n-40) and healthy controls (n=40) to understand the biological basis of depression within the unique ethnic and environmental context of Sikkim. Females were the majority in both MDD (67.5%) and control (70%) groups. Most participants had a normal BMI (MDD: 62.5%, Control: 67.5%), with few cases of obesity or underweight. Nepali ethnicity was predominant in both MDD: 80% and,Control: 77.5% followed by Bhutias and others however statistically insignificant. hs-CRP differed significantly between MDD (3335.7 pg/L) and controls (3164.7 pg/L) P< 0.05, though it did not vary by depression severity. hs-CRP showed fair diagnostic ability (AUC = 0.746, 95% CI: 0.638–0.854, P< 0.01; sensitivity 65%, specificity 77.5%), whereas IL-1β demonstrated poor performance. hs–CRP shows potential as an adjunct inflammatory marker in assessing depression. Future studies should explore composite biomarker approach combined with clinical tools to enhance diagnostic and treatment strategies.

Downloads

Published

2026-07-21

Issue

Section

Papers

How to Cite

Comparative analysis of serum hs-CRP and IL-1β levels in major depressivedisorder patients and healthy controls in a tertiary care setting in Sikkim. (2026). Indian Journal of Biochemistry and Biophysics (IJBB), 63(8), 923-929. https://doi.org/10.56042/ijbb.v63i8.26002

Similar Articles

1-10 of 349

You may also start an advanced similarity search for this article.